dc.creator | Spanos K., Saleptsis V., Athanasoulas A., Karathanos C., Bargiota A., Chan P., Giannoukas A.D. | en |
dc.date.accessioned | 2023-01-31T10:00:48Z | |
dc.date.available | 2023-01-31T10:00:48Z | |
dc.date.issued | 2017 | |
dc.identifier | 10.1177/0003319717700971 | |
dc.identifier.issn | 00033197 | |
dc.identifier.uri | http://hdl.handle.net/11615/79298 | |
dc.description.abstract | [No abstract available] | en |
dc.language.iso | en | en |
dc.source | Angiology | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019695419&doi=10.1177%2f0003319717700971&partnerID=40&md5=711f25bf1e9902cfb4f44985c398c10f | |
dc.subject | C reactive protein | en |
dc.subject | ertapenem | en |
dc.subject | hydroxymethylglutaryl coenzyme A reductase inhibitor | en |
dc.subject | metalloproteinase | en |
dc.subject | piperacillin plus tazobactam | en |
dc.subject | coronary artery disease | en |
dc.subject | diabetic foot | en |
dc.subject | diabetic foot infection | en |
dc.subject | disease classification | en |
dc.subject | human | en |
dc.subject | Letter | en |
dc.subject | peripheral occlusive artery disease | en |
dc.subject | prognosis | en |
dc.subject | protein expression | en |
dc.subject | skin infection | en |
dc.subject | prognosis | en |
dc.subject | Diabetic Foot | en |
dc.subject | Humans | en |
dc.subject | Prognosis | en |
dc.subject | SAGE Publications Inc. | en |
dc.title | Re: "prognostic Factors in Diabetic Foot Ulcer" | en |
dc.type | other | en |